Apotex Inc.: Clinical Trials

10 trials sponsored by Apotex Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 1 active not recruiting, 1 recruiting. 4 Phase 3, 3 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Unknown 1
Phase 23Active not recruiting 1, Completed 1, Unknown 1
Phase 11Completed 1
Phase 41Unknown 1

Follow Apotex Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enoxacin for Amyotrophic Lateral Sclerosis (ALS)
Enoxacin, Placebo - Amyotrophic Lateral Sclerosis
Phase 1 / Phase 2CompletedMcGill University82021-03-262024-01-26
Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
Artesunate, Imatinib, Infliximab - COVID-19
Phase 3UnknownSunnybrook Health Sciences Centre29002020-03-182023-10-13
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
Acetylsalicylic acid, Placebo - Ovarian Cancer Prevention
Phase 2Active not recruitingCanadian Cancer Trials Group1172018-07-242026-09-16
A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis
Azelastine HCl and Fluticasone Propionate Nasal Spray, 137 µg/50 µg per spray, Dymista™ Nasal Spray, Placebo - Seasonal Allergic Rhinitis
Phase 2UnknownApotex Inc.5952013-12-012014-10-31
The Mycophenolate Pregnancy Registry
Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
CompletedGenentech, Inc.4002012-11-202026-10-13
A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis
Ciclesonide nasal spray, 50 μg per actuation. - Seasonal Allergic Rhinitis
Phase 3CompletedApotex Inc.5802011-03-012014-10-24
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
Imiquimod 5%: manufactured by Apotex, Adara 5% Cream US, Adara 5% Cream Canada - Actinic Keratosis
Phase 3CompletedApotex Inc.4972008-02-012009-03-10
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
deferiprone - Beta-Thalassemia
Phase 4UnknownRoyal Brompton & Harefield NHS Foundation Trust652004-05-012005-06-24
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
HIV Infections, Hepatitis B
RecruitingSyneos Health242581991-07-212026-11-19
A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis
triamcinolone acetonide aqueous nasal spray (Apotex Inc.), triamcinolone acetonide aqueous nasal spray (Nasacort® AQ), Placebo - Seasonal Allergic Rhinitis
Phase 3CompletedApotex Inc.2009-09-30

Conditions studied

Rhinitis, Allergic, Seasonal (3)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Autoimmune Diseases (1)  ·  COVID-19 (1)  ·  HIV Infections (1)  ·  Hepatitis (1)  ·  Hepatitis B (1)  ·  Keratosis, Actinic (1)  ·  beta-Thalassemia (1)

Interventions

Artesunate (1)  ·  Aspirin (1)  ·  Deferiprone (1)  ·  Dexamethasone (1)  ·  Enoxacin (1)  ·  Imatinib Mesylate (1)  ·  Imiquimod (1)  ·  Infliximab (1)  ·  azelastine (1)

Countries

Canada (3)  ·  United States (3)  ·  Australia (1)  ·  Italy (1)

Top investigators

Amit Oza (1)  ·  Angela Genge, MD, FRCP (1)  ·  Jessica D Albano, PhD, MPH (1)  ·  Srinivas Murthy, MD (1)  ·  Stephanie Lheureux (1)  ·  William Brooks (1)

Results publications

PMID 18298856, PMID 26269220, PMID 26687320, PMID 33264556, PMID 34350582, PMID 35045989, PMID 35609913, PMID 36036936, PMID 36199248, PMID 36695483